EAGLE ASSET MANAGEMENT INC - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 206 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q3 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.0%.

Quarter-by-quarter ownership
EAGLE ASSET MANAGEMENT INC ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$1,733,868
-56.6%
37,701
-45.8%
0.01%
-54.5%
Q2 2023$3,999,279
-65.2%
69,589
-77.3%
0.02%
-67.2%
Q1 2023$11,503,000
+35.6%
306,770
+2.0%
0.07%
+28.8%
Q4 2022$8,484,000
-2.7%
300,873
-3.0%
0.05%
-8.8%
Q3 2022$8,718,000
+10.2%
310,255
+36.4%
0.06%
+14.0%
Q2 2022$7,913,000
+24.3%
227,459
+28.3%
0.05%
+51.5%
Q1 2022$6,366,000
+9.3%
177,339
-29.5%
0.03%
+26.9%
Q4 2021$5,822,000
+7.6%
251,616
-11.6%
0.03%
+8.3%
Q3 2021$5,410,000
-11.9%
284,618
-6.5%
0.02%
-7.7%
Q2 2021$6,138,000
+9.3%
304,474
-1.9%
0.03%
+4.0%
Q1 2021$5,616,000
-10.6%
310,459
-0.6%
0.02%
-28.6%
Q4 2020$6,282,000
+18.6%
312,423
+9.9%
0.04%
+29.6%
Q3 2020$5,295,000
-20.5%
284,244
-5.6%
0.03%
-28.9%
Q2 2020$6,662,000
+41.2%
301,218
-5.3%
0.04%
+31.0%
Q1 2020$4,718,000
-13.9%
317,988
+11.9%
0.03%
+11.5%
Q4 2019$5,482,000284,2360.03%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q3 2022
NameSharesValueWeighting ↓
Alambic Investment Management, L.P. 29,423$583,0000.44%
Matarin Capital Management, LLC 223,184$4,426,0000.34%
Summit Global Investments 42,725$847,0000.10%
FEDERATED HERMES, INC. 1,747,921$34,661,0000.08%
ROTHSCHILD & CO ASSET MANAGEMENT US INC. 347,307$6,887,0000.08%
MARSHALL WACE, LLP 413,293$8,196,0000.06%
BOSTON ADVISORS LLC 42,365$840,0000.04%
MARTINGALE ASSET MANAGEMENT L P 214,444$4,254,0000.04%
JACOBS LEVY EQUITY MANAGEMENT, INC 177,321$3,516,0000.04%
SILVERCREST ASSET MANAGEMENT GROUP LLC 231,041$4,582,0000.04%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders